Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes treatment and weight management. Our facility offers high-quality tirzepatide at competitive prices for research purposes.
The compound demonstrates superior efficacy in glucose control and weight reduction compared to selective GLP-1 receptor agonists. Tirzepatide's unique molecular structure features PEG modification that enhances water solubility while maintaining biological activity.
Clinical trials have shown significant weight loss results with tirzepatide therapy. In the SURMOUNT-1 study, participants achieved average weight reductions of 15-20.9% depending on dosage after 72 weeks of treatment.
As a weekly administered dual agonist, tirzepatide represents an innovative approach in metabolic disorder treatment by combining the effects of two incretin hormones in a single molecule formulation.
Our production follows strict quality control measures to ensure batch-to-batch consistency. We offer flexible packaging options to meet various research requirements while maintaining competitive tirzepatide prices for bulk orders.
Proper storage is essential for maintaining peptide stability. We recommend storing tirzepatide in a cool, dry environment protected from light and moisture. Avoid repeated freeze-thaw cycles and prolonged exposure to solution phase.
For researchers seeking reliable tirzepatide prices without compromising quality, our facility provides pharmaceutical-grade material suitable for preclinical and clinical studies. The compound's dual mechanism of action offers unique research opportunities in metabolic disease pathways.
Note: This product is intended for research use only. Not for human consumption or diagnostic use.
